Editorial COVID-19
Jaleh Barar* ORCID
Bioimpacts. 2020;10(3): 137-138. doi: 10.34172/bi.2020.16
PMCID: PMC7416010     PMID: 32793434     Scopus ID: 85089709760    
The vast knowledge about the pathways that regulate the virus entry and molecular signaling of the pathogenesis of coronavirus are the key factor for the development of de novo nanoscaled diagnostic/therapeutic strategies.
Prospective Highlights COVID-19
Morteza Mahmoudi* ORCID, Loraleigh Keashly
Bioimpacts. 2020;10(3): 139-140. doi: 10.34172/bi.2020.17
PMCID: PMC7416009     PMID: 32793435     Scopus ID: 85089707838    
In this perspective piece we will explore the potential facilitative influence of COVID-19 and specifically responses to it, on bullying behaviors in academic and research environments.
Original Research
Siddharth Singh Yadav, Basant Singh Sikarwar* ORCID, Priya Ranjan, Rajiv Janardhanan
Bioimpacts. 2020;10(3): 141-150. doi: 10.34172/bi.2020.18
PMCID: PMC7416008     PMID: 32793436     Scopus ID: 85089711145    
We proposed making a case for the validation of a low-cost version of a microfluidic system capable of scanning large populations for a variety of diseases as per the WHO mandate of “One Health”.
Original Research
Jeanne Akissi Koffi* ORCID, Kigbafori Dieudonné Silué, Dominique Konan Tano, Trésor Marius Dable, William Yavo
Bioimpacts. 2020;10(3): 151-157. doi: 10.34172/bi.2020.19
PMCID: PMC7416013     PMID: 32793437     Scopus ID: 85089707941    
The antiplasmodial properties of these plants could partially justify their use in malaria treatment.
Original Research
Shahin Alizadeh-Fanalou ORCID, Ali Nazarizadeh ORCID, Mohammad Babaei ORCID, Mohsen Khosravi ORCID, Navid Farahmandian, Elham Bahreini* ORCID
Bioimpacts. 2020;10(3): 159-167. doi: 10.34172/bi.2020.20
PMCID: PMC7416011     PMID: 32793438     Scopus ID: 85089710918    
Glibenclamide was more effective than the highest dose of Securigera securidaca seed extract inincreasing PON1 activity, but the extract was more effective than glibenclamide in decreasing lipidperoxidation and cardiovascular risk indices.
Original Research
Zahra Hajati ORCID, Farhad Sadegh Moghanlou* ORCID, Mohammad Vajdi ORCID, Seyed Esmail Razavi, Somaieh Matin ORCID
Bioimpacts. 2020;10(3): 169-175. doi: 10.34172/bi.2020.21
PMCID: PMC7416012     PMID: 32793439     Scopus ID: 85078309726    
The blood flow around a venous valve was investigated numerically. The leaflets were considered as hyperelastic material. The simulation gives detailed information about the blood and leaflets behavior which can be used in treatment of vein diseases.
Original Research
Mozhgan Ghobadi Pour ORCID, Naser Mirazi* ORCID, Hojatollah Alaei, Maryam Radahmadi, Ziba Rajaei, Alireza Monsef Esfahani
Bioimpacts. 2020;10(3): 177-186. doi: 10.34172/bi.2020.22
PMCID: PMC7416014     PMID: 32793440     Scopus ID: 85089309823    
The rat cirrhotic model is made by using thioacetamide hepatotoxin for 18 weeks. The cirrhotic rats treated to some degrees by using lactulose and silymarin known standard drugs for 8 weeks.
Original Research
Siamak Alizadeh, Abolfazl Barzegari, Abolghasem Esmaeili*, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(3): 187-193. doi: 10.34172/bi.2020.23
PMCID: PMC7416006     PMID: 32793441     Scopus ID: 85089711371    
E. coli Nissle 1917 (EcN) is proposed as an appropriate light-activated vehicle for delivery of anticancer agents to the cancer cells/tissues such colorectal cancer.
Clarence S Yah* ORCID, Geoffrey S. Simate
Bioimpacts. 2020;10(3): 195-203. doi: 10.34172/bi.2020.24
PMCID: PMC7416007     PMID: 32793442     Scopus ID: 85089711934    
The impact of bio-nanomaterials XCELLigence-cytotoxicity testing. A non-invasive in-vitro monitoring process that mimics exact continuous cellular bio-responses. However, to expand and affirm consumer safety concerns of bio-nanomaterials, additional XCELLigence data is required for bio-nanomaterials toxicity protocols and methodological development.
Letter to the Editor COVID-19
Yosef Masoudi-Sobhanzadeh* ORCID
Bioimpacts. 2020;10(3): 205-206. doi: 10.34172/bi.2020.25
PMCID: PMC7416005     PMID: 32793443     Scopus ID: 85089710496    
This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.